Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors

被引:16
|
作者
Wang, Ziqian [1 ]
Xu, Wenjie [1 ]
Song, Ting [2 ]
Guo, Zongwei [2 ]
Liu, Lu [1 ]
Fan, Yudan [2 ]
Wang, Anhui [1 ]
Zhang, Zhichao [1 ]
机构
[1] Dalian Univ Technol, Sch Chem, State Key Lab Fine Chem, Dalian 116012, Peoples R China
[2] Dalian Univ Technol, Sch Life Sci & Technol, Dalian, Peoples R China
基金
中国国家自然科学基金;
关键词
Fragment-based drug design; Ligand efficiency; Mcl-1; inhibitor; p1; pocket; Selective; BCL-2; FAMILY; DRUG DESIGN; ABT-737; DISCOVERY; PROTEINS; POTENT; ANTAGONISTS; RESISTANCE; APOPTOSIS; BIG;
D O I
10.1002/ardp.201600251
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Based on a known selective Mcl-1 inhibitor, 6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-1H-indole-2-carboxylic acid, we applied a fragment-based approach to obtain new molecules that extended into the p1 pocket of the BH3 groove and then exhibited binding selectivity for the Mcl-1 over the Bcl-2 protein. After we deconstructed the 1H-indole-2-carboxylic acid from the parental molecule, a benzenesulfonyl was substituted at the 1-position to adopt a geometry preferred for accessing the p1 pocket according to the binding mode of the parental molecule identified by X-ray crystallography. A linear relationship between the free energy of ligand binding (Delta G) and the count of non-hydrogen heavy atoms (HAC) was maintained during the molecular growing to occupy the p1 pocket. Finally, we not only obtained compound 12 with a 7.5-fold selectivity to Mcl-1 (K-i = 0.48 mu M by fluorescence polarization) over Bcl-2 (K-i = 3.6 mu M), but also provided evidence that additional occupation of the p1 pocket is more favorable for Mcl-1 than for Bcl-2 binding, and contributes more to Mcl-1 inhibition than occupation of the p2 pocket. Compound 12 exhibited a selective killing ability on Mcl-1-dependent cancer cells.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Fragment-based design, synthesis, and biological evaluation of N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide derivatives as novel Mcl-1 inhibitors
    Zhang, Zhichao
    Liu, Chengwu
    Li, Xiangqian
    Song, Ting
    Wu, Zhiyong
    Liang, Xiaomeng
    Zhao, Yan
    Shen, Xiaoyun
    Chen, Hongbo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 60 : 410 - 420
  • [2] Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods
    Pelz, Nicholas F.
    Bian, Zhiguo
    Zhao, Bin
    Shaw, Subrata
    Tarr, James C.
    Belmar, Johannes
    Gregg, Claire
    Camper, DeMarco V.
    Goodwin, Craig M.
    Arnold, Allison L.
    Sensintaffar, John L.
    Friberg, Anders
    Rossanese, Olivia W.
    Lee, Taekyu
    Olejniczak, Edward T.
    Fesik, Stephen W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 2054 - 2066
  • [3] Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors
    Liu, Tingting
    Wan, Yichao
    Liu, Renshuai
    Ma, Lin
    Li, Minyong
    Fang, Hao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (06) : 1939 - 1948
  • [4] 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation
    Xu, Guangsen
    Liu, Tingting
    Zhou, Yi
    Yang, Xinying
    Fang, Hao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (20) : 5548 - 5556
  • [5] Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors
    Liang, Xiao
    Li, Xue
    Zhao, Zhiyuan
    Nie, Yiming
    Yao, Zefu
    Ren, Wandi
    Yang, Xinying
    Hou, Xuben
    Fang, Hao
    BIOORGANIC CHEMISTRY, 2022, 121
  • [6] Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors
    Liu, Lulu
    Liu, Renshuai
    Yang, Xinying
    Hou, Xuben
    Fang, Hao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 191
  • [7] Structure-based design, synthesis, and evaluation of Bcl-2/Mcl-1 dual inhibitors
    Zhu, Junjie
    Wang, Ziqian
    Guo, Zongwei
    Zhang, Xiaodong
    Song, Ting
    Guo, Yafei
    Ji, Tong
    Zhang, Zhichao
    ARCHIV DER PHARMAZIE, 2020, 353 (05)
  • [8] Substituted indole Mcl-1 inhibitors: a patent evaluation (WO2015148854A1)
    Song, Ting
    Wang, Ziqian
    Zhang, Zhichao
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (11) : 1227 - 1238
  • [9] Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
    Friberg, Anders
    Vigil, Dominico
    Zhao, Bin
    Daniels, R. Nathan
    Burke, Jason P.
    Garcia-Barrantes, Pedro M.
    Camper, DeMarco
    Chauder, Brian A.
    Lee, Taekyu
    Olejniczak, Edward T.
    Fesik, Stephen W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (01) : 15 - 30
  • [10] Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bc1-xL inhibitors
    Li, Rongshi
    Cheng, Chunwei
    Balasis, Maria E.
    Liu, Yan
    Garner, Thomas P.
    Daniel, Kenyon G.
    Li, Jerry
    Qin, Yong
    Gavathiotis, Evripidis
    Sebti, Said M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 90 : 315 - 331